JP2002529497A5 - - Google Patents

Download PDF

Info

Publication number
JP2002529497A5
JP2002529497A5 JP2000582023A JP2000582023A JP2002529497A5 JP 2002529497 A5 JP2002529497 A5 JP 2002529497A5 JP 2000582023 A JP2000582023 A JP 2000582023A JP 2000582023 A JP2000582023 A JP 2000582023A JP 2002529497 A5 JP2002529497 A5 JP 2002529497A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
halogen
different
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000582023A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002529497A (ja
JP4610086B2 (ja
Filing date
Publication date
Priority claimed from SE9803953A external-priority patent/SE9803953D0/xx
Priority claimed from SE9803952A external-priority patent/SE9803952D0/xx
Application filed filed Critical
Priority claimed from PCT/SE1999/002093 external-priority patent/WO2000028975A2/en
Publication of JP2002529497A publication Critical patent/JP2002529497A/ja
Publication of JP2002529497A5 publication Critical patent/JP2002529497A5/ja
Application granted granted Critical
Publication of JP4610086B2 publication Critical patent/JP4610086B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000582023A 1998-11-18 1999-11-15 改善された化学的方法および医薬処方物 Expired - Fee Related JP4610086B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9803953A SE9803953D0 (sv) 1998-11-18 1998-11-18 Improved chemical process
SE9803952A SE9803952D0 (sv) 1998-11-18 1998-11-18 Pharmaceutical formulation
SE9803952-2 1998-11-18
SE9803953-0 1998-11-18
PCT/SE1999/002093 WO2000028975A2 (en) 1998-11-18 1999-11-15 Improved chemical process and pharmaceutical formulation

Publications (3)

Publication Number Publication Date
JP2002529497A JP2002529497A (ja) 2002-09-10
JP2002529497A5 true JP2002529497A5 (https=) 2007-01-11
JP4610086B2 JP4610086B2 (ja) 2011-01-12

Family

ID=26663439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000582023A Expired - Fee Related JP4610086B2 (ja) 1998-11-18 1999-11-15 改善された化学的方法および医薬処方物

Country Status (18)

Country Link
US (1) US6403616B1 (https=)
EP (1) EP1131316B1 (https=)
JP (1) JP4610086B2 (https=)
KR (1) KR100619200B1 (https=)
CN (1) CN100503598C (https=)
AT (1) ATE271556T1 (https=)
AU (1) AU770633B2 (https=)
BR (1) BR9915421A (https=)
CA (1) CA2347981C (https=)
DE (1) DE69918854T2 (https=)
DK (1) DK1131316T3 (https=)
ES (1) ES2222754T3 (https=)
HK (1) HK1038920B (https=)
IL (2) IL142629A0 (https=)
NO (1) NO321275B1 (https=)
NZ (1) NZ511169A (https=)
PT (1) PT1131316E (https=)
WO (1) WO2000028975A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
AU2007266574A1 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
EP3372080A3 (en) 2011-11-10 2018-10-17 Rotam Agrochem International Co., Ltd Herbicidal composition and method of using the same
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DE69127275T2 (de) * 1991-06-21 1998-03-12 Ilsan Ilac Ve Hammaddeleri San Neues galenisches Verfahren für Omeprazol enthaltende Pellets
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
TNSN95062A1 (fr) * 1994-05-27 1996-02-06 Astra Ab Nouveaux derives dialkoxy-pyridinyle-benzimidazole
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
AUPN846496A0 (en) * 1996-03-05 1996-03-28 Research Laboratories Of Australia Pty Ltd Electronic printing for display technology
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
CN1134667C (zh) * 1996-05-17 2004-01-14 福姆法克特公司 微电子弹性接触元件
CN1128997C (zh) * 2001-01-04 2003-11-26 中国科学院南京土壤研究所 一种吸力平板的制作方法

Similar Documents

Publication Publication Date Title
AU780678B2 (en) New use of compounds as antibacterial agents
JP2009504763A5 (https=)
JP2002529497A5 (https=)
US20040077869A1 (en) Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
TNSN05165A1 (fr) Derives de pyrrolopyrimidine
ES2781681T3 (es) Profármacos de ésteres de [3-(1-(1H-imidazol-4-il)etil)-2-metilfenil]-metanol para reducir la presión intraocular
RU2002107975A (ru) Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения
JP2007507494A5 (https=)
JP2004512328A5 (https=)
IN2015DN01132A (https=)
RU94044671A (ru) Применение непептидных антагонистов рецептора тахикинина
JP2001526218A5 (https=)
KR900701759A (ko) 비-펩타이드 레닌 억제제
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
RU2004132856A (ru) Фармацевтический препарат с модифицированным высвобождением
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
UA64715C2 (en) Pharmaceutical composition with extended release of h+, k+-atpase inhibitor (variants) and method for enhancing inhibition of acid secretion in stomach
NO20055655D0 (no) Anvendelse av azetidinkarboksamidderivater i terapi
RU2002133458A (ru) Соединения пиперазина и пиперидина
JP2018507257A5 (https=)
JOP20240217A1 (ar) مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة
HUP0203121A2 (hu) Szubsztituált benzimidazolokat tartalmazó gyógyszerkészítmény és alkalmazása
JP2003512327A5 (https=)
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
CA2347981A1 (en) Process for the manufacturing of alkaline salts of substituted sulphinyl compounds and products prepared thereby